Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Subcapsular Diluted Terlipressin Versus Placebo in Reducing Intraoperative Blood Loss During Myomectomy: A Randomized, Double-Blind, Placebo-Controlled Trial

NCT07746349 is registered in ClinicalTrials.gov with Sevil Cankaya as lead sponsor.

NCT NCT07746349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07746349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Subcapsular Diluted Terlipressin Versus Placebo in Reducing Intraoperative Blood Loss During Myomectomy: A Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
Sevil Cankaya
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
January 31, 2027
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leiomyoma, uterine fibroids (leiomyoma), uterine myoma